Prednisolone (injection)

Revision as of 18:40, 27 September 2011 by WikiBot (talk | contribs) (Protected "Prednisolone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Prednisolone (injection)
Clinical data
ATC code
Pharmacokinetic data
Elimination half-life2-3 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H28O5
Molar mass360.444 g/mol

WikiDoc Resources for Prednisolone (injection)

Articles

Most recent articles on Prednisolone (injection)

Most cited articles on Prednisolone (injection)

Review articles on Prednisolone (injection)

Articles on Prednisolone (injection) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Prednisolone (injection)

Images of Prednisolone (injection)

Photos of Prednisolone (injection)

Podcasts & MP3s on Prednisolone (injection)

Videos on Prednisolone (injection)

Evidence Based Medicine

Cochrane Collaboration on Prednisolone (injection)

Bandolier on Prednisolone (injection)

TRIP on Prednisolone (injection)

Clinical Trials

Ongoing Trials on Prednisolone (injection) at Clinical Trials.gov

Trial results on Prednisolone (injection)

Clinical Trials on Prednisolone (injection) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Prednisolone (injection)

NICE Guidance on Prednisolone (injection)

NHS PRODIGY Guidance

FDA on Prednisolone (injection)

CDC on Prednisolone (injection)

Books

Books on Prednisolone (injection)

News

Prednisolone (injection) in the news

Be alerted to news on Prednisolone (injection)

News trends on Prednisolone (injection)

Commentary

Blogs on Prednisolone (injection)

Definitions

Definitions of Prednisolone (injection)

Patient Resources / Community

Patient resources on Prednisolone (injection)

Discussion groups on Prednisolone (injection)

Patient Handouts on Prednisolone (injection)

Directions to Hospitals Treating Prednisolone (injection)

Risk calculators and risk factors for Prednisolone (injection)

Healthcare Provider Resources

Symptoms of Prednisolone (injection)

Causes & Risk Factors for Prednisolone (injection)

Diagnostic studies for Prednisolone (injection)

Treatment of Prednisolone (injection)

Continuing Medical Education (CME)

CME Programs on Prednisolone (injection)

International

Prednisolone (injection) en Espanol

Prednisolone (injection) en Francais

Business

Prednisolone (injection) in the Marketplace

Patents on Prednisolone (injection)

Experimental / Informatics

List of terms related to Prednisolone (injection)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Prednisolone is the active metabolite of prednisone.

Prednisolone has an extremely bitter taste that makes it difficult to administer to children.

Uses

It is a corticosteroid drug with predominantly glucocorticoid and low mineralocorticoid activity, making it useful for the treatment of a wide range of inflammatory and auto-immune conditions such as asthma, rheumatoid arthritis, Ulcerative Colitis and Crohn's disease, multiple sclerosis, cluster headaches and Systemic Lupus Erythematosus. It can also be used as an immunosuppressive drug for organ transplants and in cases of adrenal insufficiency (Addison's). Prednisolone acetate ophthalmic suspension is an adrenocortical steroid product prepared as a sterile ophthalmic suspension, used to reduce swelling, redness, itching, and allergic reactions affecting the eye. Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation. There is no generally-accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Corticosteriods are capable of producing a rise in intraocular pressure.

Possible Side-Effects

Possible side-effects include fluid retention of the face (moon face, Cushing's syndrome), acne, constipation, and mood swings. A lengthy course of prednisolone can cause bloody or black tarry stools; filling or rounding out of the face; muscle cramps or pain; muscle weakness; nausea; pain in back, hips, ribs, arms, shoulders, or legs; reddish-purple lines on arms, face, legs, trunk or groin; thin and shiny skin; unusual bruising; urinating at night; rapid weight gain; and wounds that will not heal. Swelling of the pancreas has also been reported. Other effects include decreased or blurred vision, increased thirst, confusion, and nervousness. It also is reported to cause insomnia when large strengths, or large doses are taken.

Systemically: Posterior subcapsular cataracts & papilledema

Topical: PSC & glaucoma

Contraindicated with herpes

Banned Status in Athletics

As a glucocorticosteroid, prednisolone is banned under WADA anti-doping rules.

Template:Corticosteroids Template:Antidiarrheals, intestinal anti-inflammatory/anti-infective agents Template:Vasoprotectives Template:Corticosteroids for systemic use

Template:Otologicals
de:Prednisolon ko:프레드니솔론 hu:Prednizolon

Template:WH Template:WS Template:Jb1